{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T04:14:08Z","timestamp":1688271248720},"reference-count":11,"publisher":"The Editorial Committee of Annals of Vascular Diseases","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Vascular Diseases","Ann Vasc Dis","AVD"],"published-print":{"date-parts":[[2023,6,25]]},"DOI":"10.3400\/avd.cr.22-00130","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T22:11:42Z","timestamp":1686694302000},"page":"146-149","source":"Crossref","is-referenced-by-count":0,"title":["Improvement in Quality of Life Following Celiprolol Hydrochloride Administration in a Patient with Vascular Ehlers\u2013Danlos Syndrome: A Case Report"],"prefix":"10.3400","volume":"16","author":[{"given":"Kanichiro","family":"Shimizu","sequence":"first","affiliation":[{"name":"Department of Radiology, Kashiwa Hospital, The Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Kameoka","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kashiwa Hospital, The Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Motohashi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kashiwa Hospital, The Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Munetomo","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kashiwa Hospital, The Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kurata","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kashiwa Hospital, The Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Sadaoka","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kyoundo Hospital of the Sasaki Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1983","reference":[{"key":"1","unstructured":"1) Byers PH. Vascular Ehlers-Danlos Syndrome. GeneReviews<sup>\u00ae<\/sup>[Internet], 2019. Retrieved May 22, 2023, from https:\/\/www.ncbi.nlm.nih.gov\/sites\/books\/NBK1494\/"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Ong KT, Perdu J, De Backer J, et al. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet 2010; <b>376<\/b>: 1476-84.","DOI":"10.1016\/S0140-6736(10)60960-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Pepin MG, Schwarze U, Rice KM, et al. Survival is affected by mutation type and molecular mechanism in vascular Ehlers\u2013Danlos syndrome (EDS type IV). Genet Med 2014; <b>16<\/b>: 881-8.","DOI":"10.1038\/gim.2014.72"},{"key":"4","unstructured":"4) Malfait F, Francomano C, Byers P, et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet 2017; <b>175<\/b>: 8-26."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Byers PH, Belmont J, Black J, et al. Diagnosis, natural history, and management in vascular Ehlers\u2013Danlos syndrome. Am J Med Genet C Semin Med Genet 2017; <b>175<\/b>: 40-7.","DOI":"10.1002\/ajmg.c.31553"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Sugawara Y, Ban K, Imai K, et al. Successful coil embolization for spontaneous arterial rupture in association with Ehlers-Danlos syndrome type IV: report of a case. Surg Today 2004; <b>34<\/b>: 94-6.","DOI":"10.1007\/s00595-003-2634-z"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kamalanathan KC, Barnacle AM, Holbrook C, et al. Splenic rupture secondary to vascular Ehlers\u2013Danlos syndrome managed by coil embolization of the splenic artery. European J Pediatr Surg Rep 2019; <b>7<\/b>: e83-5.","DOI":"10.1055\/s-0039-3399555"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Malz SB, Fantus RJ, Mellett MM, et al. Surgical complication of Ehlers-Danlos syndrome type IV: case report and review of the literature. J Trauma 2001; <b>51<\/b>: 387-90.","DOI":"10.1097\/00005373-200108000-00029"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Xiao N, Lewandowski RJ. Embolic agents: coils. In: Ray CE Jr ed. Seminars in Interventional Radiology. New York: Thieme Medical Publishers, Inc, 2022: 113-8.","DOI":"10.1055\/s-0041-1740939"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Hill H, Chick JFB, Hage A, et al. N-butyl cyanoacrylate embolotherapy: technique, complications, and management. Diagn Interv Radiol 2018; <b>24<\/b>: 98-103.","DOI":"10.5152\/dir.2018.17432"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Baderkhan H, Wanhainen A, Stenborg A, et al. Celiprolol treatment in patients with vascular Ehlers-Danlos Syndrome. Eur J Vasc Endovasc Surg 2021; <b>61<\/b>: 326-31.","DOI":"10.1016\/j.ejvs.2020.10.020"}],"container-title":["Annals of Vascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/avd\/16\/2\/16_cr.22-00130\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T04:42:15Z","timestamp":1688186535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/avd\/16\/2\/16_cr.22-00130\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,25]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.3400\/avd.cr.22-00130","relation":{},"ISSN":["1881-641X","1881-6428"],"issn-type":[{"value":"1881-641X","type":"print"},{"value":"1881-6428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,25]]},"article-number":"cr.22-00130"}}